Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive Disorder

NCT00844194 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathies
Depressive Disorder, Major

Interventions

DRUG: Duloxetine 60 mg QD
DRUG: Duloxetine 60 mg QD
DRUG: Duloxetine 30 mg QD
DRUG: Duloxetine 30 mg QD
DRUG: Duloxetine 90 mg QD
DRUG: Duloxetine 90 mg QD
DRUG: Duloxetine 60 mg QD
DRUG: Duloxetine 60 mg QD
DRUG: Duloxetine 120 mg QD
DRUG: Duloxetine 30 mg QD
DRUG: Duloxetine 30 mg QD
DRUG: Duloxetine 120 mg QD

Sponsor

Boehringer Ingelheim